Basilea Pharmaceutica AG (BPMUF.PK)

BPMUF.PK

About

Basilea Pharmaceutica AG is a Switzerland-based company engaged in the research, development and commercialization of pharmaceutical products. The Company focuses its activities on the areas of antibiotics and antifungal, as well as on the development of oncology and dermatology drugs. It marketed its product Toctino, treatment... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	1.94
Market Cap (Mil.):	CHF651.95
Shares Outstanding (Mil.):	9.59
Dividend:	5.00
Yield (%):	7.35

Financials

	BPMUF.PK	Industry	Sector
P/E (TTM):	--	34.04	34.30
EPS (TTM):	-5.53	--	--
ROI:	-20.41	19.04	18.43
ROE:	-40.99	19.78	19.30

Latest News about BPMUF.PK

CORRECTED-Basilea shareholder requests repayment of capital

ZURICH, Feb 25 - HBM Healthcare Investments has called on Swiss biotech group Basilea to repay 5 Swiss francs ($5.4) per registered share from the company's capital reserves, a move that would cost roughly 48 million francs.

25 Feb 2013

Basilea shareholder requests repayment of capital

ZURICH, Feb 23 - HBM Healthcare Investments has called on Swiss biotech group Basilea to repay 5 Swiss francs ($5.4) per registered share from the company's capital reserves, a move that would cost roughly 48 million francs.

23 Feb 2013

Basilea CFO quits two months after CEO

* Basilea expects potential ceftobiprole approval in Q4 2013

07 Feb 2013

» More BPMUF.PK News

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Basilea Pharmaceutica AG (BSLN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Provider: GlobalData	$250.00 Buy
Basilea Pharmaceutica AG: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
BASILEA - ISA INTEREST INTENSIFIES Provider: Edison Investment Research	$10.00 Buy
BASILEA - NEW EMPHASIS Provider: Edison Investment Research	$10.00 Buy
BASILEA - CATALYSTS IN VIEW Provider: Edison Investment Research	$10.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.